Preoperative Partitioning of Pulmonary Vascular Resistance Correlates with Early Outcome after Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension

Circulation

Volumn 109, Issue 1, 2004, Pages 18-22

  Kim, Nick H S ^a   Fesler, Pierre ^b   Channick, Richard N ^a   Knowlton, Kirk U ^a   Ben Yehuda, Ori ^a   Lee, Stephen H ^a   Naeije, Robert ^b   Rubin, Lewis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Endarterectomy; Hypertension, pulmonary; Occlusion; Pulmonary heart disease

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; COR PULMONALE; CORRELATION ANALYSIS; ENDARTERECTOMY; FEMALE; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; AGED; CATHETERIZATION, SWAN-GANZ; CHRONIC DISEASE; ENDARTERECTOMY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PREOPERATIVE CARE; PULMONARY ARTERY; PULMONARY EMBOLISM; PULMONARY WEDGE PRESSURE; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 0346096812     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000111841.28126.D4     Document Type: Article

References (19)

1. Fedullo PF, Auger WR, Kerr KM, et al. Chronic thromboembotic pulmonary hypertension. N Engl J Med. 2002;345:1465-1472.
2. Jamieson SW, Kapelanski DP. Pulmonary endarterectomy. Curr Probl Surg. 2000;37:165-252.
3. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103:685-692.
4. Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999;160:523-528.
5. Hakim TS, Michel RP, Chang HK. Partitioning of pulmonary vascular resistance in dogs by arterial and venous occlusion. J Appl Physiol. 1982;52:710-715.
6. Hakim TS, Kelly S. Occlusion pressures vs. micropipette pressures in the pulmonary circulation. J Appl Physiol. 1989;67:1277-1285.
7. Kafi SA, Melot C, Vachiery JL, et al. Partitioning of pulmonary vascular resistance in primary pulmonary hypertension. J Am Coll Cardiol. 1998;31:1372-1376.
8. Fesler P, Pagnamenta A, Vachiery JL, et al. Single arterial occlusion to locate resistance in patients with pulmonary hypertension. Eur Respir J. 2003;21:31-36.
9. Rich S, ed. Executive summary of the World Symposium on Primary Pulmonary Hypertension 1998. Available at: http://www.who.int/ncd/cvd/pph.html. Accessed October 9, 2001.
10. Baconnier PF, Eberhard A, Grimbert FA. Theoretical analysis of occlusion techniques for measuring pulmonary capillary pressure. J Appl Physiol. 1992;73:1351-1359.
11. Pagnamenta A, Bouckaert Y, Wauthy P, et al. Continuous versus pulsatile pulmonary hemodynamics in canine oleic acid lung injury. Am J Respir Crit Care Med. 2000;162:936-940.
12. Thistlethwaite PA, Mo M, Madani MM, et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg. 2002;124:1203-1211.
13. Tscholl D, Langer F, Wendler O, et al. Pulmonary thromboendarterectomy - risk factors for early survival and hemodynamic improvement. Eur J Cardiothorac Surg. 2001;19:771-776.
14. Ghofrani HA, Schermuly R, Rose F, et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2003;167:1139-1141.
15. McLaughlin VV, Genthner DE, Panella MM, et al. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series. Ann Intern Med. 1999;130:740-743.
16. Nagaya N, Sasaki N, Ando M, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest. 2003;123:338-343.
17. Nagaya N, Shimizu Y, Satoh T, et al. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart. 2002;87:340-345.
18. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347:322-329.
19. Pellett AA, Johnson RW, Morrison GG, et al. A comparison of pulmonary arterial occlusion algorithms for estimation of pulmonary capillary pressure. Am J Respir Crit Care Med. 1999;160:162-168.